3 companies settle for $745K for misbranded migraine devices

Medical device distributor Jet Medical and two related companies agreed to pay $745,000 in a Federal Food, Drug and Cosmetic Act infringement case involving migraine headache devices not approved by the FDA. 

Advertisement

The settlement includes $200,000 from Jet Medical for criminal allegations and the remaining balance from all three companies for civil allegations, according to a Jan. 4 news release from the Justice Department. The case accuses Jet Medical of distributing the Allevio SPG Nerve Block Catheter — a device marketed as a migraine treatment and sold from 2014 through 2019 — which never gained the OK from regulators and was never tested for its safety and effectiveness. 

Medical Components and Martech Medical Products are the two companies involved in the civil case. The two companies and Jet Medical allegedly “instructed, coached and encouraged medical providers to submit improper billing codes to Medicare for reimbursement of services using the Allevio device,” according to the release.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.